MICHELLE DUMESTRE: Open Payments
NPI 1427425107 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,556 in 111 payments from 16 companies in 2025. Trend: 2023 $1,256 · 2024 $1,581 · 2025 $2,556
Food & beverage: $2,556
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $549 |
| ABBVIE INC. | 28 | $476 |
| Incyte Corporation | 15 | $415 |
| Organon LLC | 14 | $204 |
| Lilly USA, LLC | 3 | $164 |
| GENZYME CORPORATION | 1 | $149 |
| Arcutis Biotherapeutics, Inc. | 8 | $143 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $79 |
| Amgen Inc. | 4 | $69 |
Products named: COSENTYX, OPZELURA, EBGLYSS, RINVOQ, Zoryve, SKYRIZI, Sotyktu, VTAMA.
Industry payments across LA — which companies pay providers there.
